Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells

References

• ArvoldNDTaghianAGNiemierkoAAge, breast cancer subtype approximation, and local recurrence after breast-conserving therapyJ Clin Oncol201129293885389121900114
   PubMed Web of Science ®Google Scholar
• LehmannBDBauerJAChenXIdentification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJ Clin Invest201112172750276721633166
   PubMed Web of Science ®Google Scholar
• LundMJButlerENHairBYAge/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first reportCancer2010116112549255920336785
   PubMed Web of Science ®Google Scholar
• Metzger-FilhoOSunZVialeGPatterns of recurrence and outcome according to breast cancer subtypes in lymph node–negative disease: results from International Breast Cancer Study Group Trials VIII and IXJ Clin Oncol201331253083309023897954
   PubMed Web of Science ®Google Scholar
• AliSCoombesRCEndocrine-responsive breast cancer and strategies for combating resistanceNat Rev Cancer20022210111212635173
   PubMed Web of Science ®Google Scholar
• HudisCAGianniLTriple-negative breast cancer: an unmet medical needOncologist201116Suppl 1111
   PubMed Web of Science ®Google Scholar
• PerouCMSørlieTEisenMBMolecular portraits of human breast tumoursNature2000406679774775210963602
   PubMed Web of Science ®Google Scholar
• MinnAJGuptaGPSiegelPMGenes that mediate breast cancer metastasis to lungNature2005436705051852416049480
   PubMed Web of Science ®Google Scholar
• Rodríguez-PinillaSMSarrióDHonradoEPrognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomasClin Cancer Res20061251533153916533778
   PubMed Web of Science ®Google Scholar
• LiedtkeCMazouniCHessKRResponse to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancerJ Clin Oncol20082681275128118250347
   PubMed Web of Science ®Google Scholar
• DentRHannaWMTrudeauMRawlinsonESunPNarodSAPattern of metastatic spread in triple-negative breast cancerBreast Cancer Res Treat2009115242342818543098
   PubMed Web of Science ®Google Scholar
• RicardoSVieiraAFGerhardRBreast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtypeJ Clin Pathol2011641193794621680574
   PubMed Web of Science ®Google Scholar
• FolkmanJKlagsbrunMAngiogenic factorsScience198723547874424472432664
   PubMed Web of Science ®Google Scholar
• HanahanDFolkmanJPatterns and emerging mechanisms of the angiogenic switch during tumorigenesisCell19968633533648756718
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• O’ReillyMSHolmgrenLShingYAngiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinomaCell19947923153287525077
   PubMed Web of Science ®Google Scholar
• WeidnerNIntratumor microvessel density as a prognostic factor in cancerAm J Pathol1995147197541613
   PubMed Web of Science ®Google Scholar
• ToiMHoshinaSTakayanagiTTominagaTAssociation of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancerCancer Sci1994851010451049
   Google Scholar
• FerraraNGerberH-PLeCouterJThe biology of VEGF and its receptorsNat Med20039666967612778165
   PubMed Web of Science ®Google Scholar
• GaspariniGPrognostic value of vascular endothelial growth factor in breast cancerOncologist20005Suppl 1374410804090
   PubMedGoogle Scholar
• PriceJEMetastasis from human breast cancer cell linesBreast Cancer Res Treat1996391931028738609
   PubMed Web of Science ®Google Scholar
• PriceDJMiralemTJiangSSteinbergRAvrahamHRole of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cellsCell Growth Differ200112312913511306513
   PubMedGoogle Scholar
• LiangYHyderSMProliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effectsEndocrinology200514683632364115845615
   PubMed Web of Science ®Google Scholar
• CookMTMafuvadzeBBesch-WillifordCEllersieckMRGoyetteSHyderSMLuteolin suppresses development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz(a)anthracene-induced mammary tumors in Sprague-Dawley ratsOncol Rep201635282583226719029
   PubMed Web of Science ®Google Scholar
• CookMTLiangYBesch-WillifordCGoyetteSMafuvadzeBHyderSMLuteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenograftsSpringerplus2015444426312209
   PubMedGoogle Scholar
• McGeeAMDouglasDLLiangYHyderSMBainesCPThe mitochondrial protein C1qbp promotes cell proliferation, migration and resistance to cell deathCell Cycle201110234119412722101277
   PubMed Web of Science ®Google Scholar
• SkehanPStorengRScudieroDNew colorimetric cytotoxicity assay for anticancer-drug screeningJ Natl Cancer Inst19908213110711122359136
   PubMed Web of Science ®Google Scholar
• ChiuFLLinJKDownregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenograftsProstate2008681617118008333
   PubMed Web of Science ®Google Scholar
• WeigeltBPeterseJLVan’t VeerLJBreast cancer metastasis: markers and modelsNat Rev Cancer20055859160216056258
   PubMed Web of Science ®Google Scholar
• BagliEStefaniotouMMorbidelliLLuteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activityCancer Res200464217936794615520200
   PubMed Web of Science ®Google Scholar
• DiasSHattoriKZhuZAutocrine stimulation of VEGFR-2 activates human leukemic cell growth and migrationJ Clin Invest2000106451110953026
   PubMed Web of Science ®Google Scholar
• DiasSChoyMAlitaloKRafiiSVascular endothelial growth factor (VEGF)–C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapyBlood20029962179218411877295
   PubMed Web of Science ®Google Scholar
• ZhangWRanSSambadeMHuangXThorpePEA monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer modelAngiogenesis200251–2354412549858
   PubMedGoogle Scholar
• PratheeshkumarPSonY-OBudhrajaALuteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesisPLoS One2012712e5227923300633
   PubMed Web of Science ®Google Scholar
• LeeE-JOhS-YSungM-KLuteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cellsFood Chem Toxicol201250114136414322926442
   PubMed Web of Science ®Google Scholar
• ZhouQYanBHuXLiXBZhangJFangJLuteolin inhibits invasion of prostate cancer PC3 cells through E-cadherinMol Cancer Ther2009861684169119509250
   PubMed Web of Science ®Google Scholar
• KimHYJungSKByunSRaf and PI3K are the molecular targets for the anti-metastatic effect of luteolinPhytother Res201327101481148823172826
   PubMed Web of Science ®Google Scholar
• LeeW-JWuL-FChenW-KWangC-JTsengT-HInhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K–Akt pathwaysChem Biol Interact2006160212313316458870
   PubMed Web of Science ®Google Scholar
• ChengW-YChiaoM-TLiangY-JYangY-CShenC-CYangC-YLuteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activityMol Biol Rep20134095315532623677714
   PubMed Web of Science ®Google Scholar
• PanduranganADharmalingamPSadagopanSGanapasamSLuteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesisHum Exp Toxicol201433111176118524532706
   PubMed Web of Science ®Google Scholar
• ParkS-HKimJ-HLeeD-HLuteolin 8-C-β-fucopyranoside inhibits invasion and suppresses TPA-induced MMP-9 and IL-8 via ERK/AP-1 and ERK/NF-κB signaling in MCF-7 breast cancer cellsBiochimie201395112082209023933110
   PubMed Web of Science ®Google Scholar
• LuJLiGHeKLuteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancerJ Transl Med2015134225638174
   PubMed Web of Science ®Google Scholar